Hodgkin's disease and intercurrent processes that may simulate a relapse

Clinical and Translational Oncology

Volumn 10, Issue 7, 2008, Pages 439-441

  Sánchez, Antonio ^a   Cantos, Blanca ^a   España, Pilar ^a   Salas, Clara ^a   Provencio, Mariano ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Hodgki s disease; Infeccion; Meningitis; Waterhouse syndrome

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIFFERENTIAL DIAGNOSIS; HODGKIN DISEASE; HUMAN; MALE; MYELOID METAPLASIA; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TUMOR RECURRENCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIAGNOSIS, DIFFERENTIAL; HODGKIN DISEASE; HUMANS; MALE; MYELOID METAPLASIA; NEOPLASM RECURRENCE, LOCAL; OPPORTUNISTIC INFECTIONS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 53749095836     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-008-0228-3     Document Type: Article

References (15)

1. Hunsaker AR, Munden RF, Pugatch RD, Mentzer SJ (1996) Sarcoid-like reaction in patients with malignancy. Radiology 200:255-261
2. Castellino RA, Podoloff DA (1999) Diagnostic radiology and nuclear medicine imaging in Hodgkin's disease. In: Mauch PM, Armitage JO, Dile V et al (eds) Hodgkin's disease. Lippincott Willians & Wilkins, Philadelphia, pp 241-262.
3. Cehreli C, Ezdinli EZ, Li CY, Krmpotic E (1976) Blastic phase of agnogenic myeloid metaplasia simulating malignant lymphoma. Cancer 38: 1297-1305
4. Lee SM, Radford JA, Ryder WDJ et al (1997) Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy. Br J Cancer 75:110-115
5. Longo DL, Duffey PL, Young RC et al (1997) Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. J Clin Oncol 10:210-218
6. Bonfante V, Santoro A, Viviani S et al (1997) Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol 15: 528-534
7. Linch DC, Winfield D, Goldstone AH et al (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet 341:1051-1054
8. Little R, Wittes RE, Longo D, Wilson WH (1998) Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplantation. J Clin Oncol 16:584-588
9. Chicote RR, Bachner RL, Hammond D (1996) Septicemia and meningitis in children splenectomized for Hodgkin's disease. N Engl J Med 295:798-800
10. Donaldson SS, Glastein E, Vosti KL (1978) Bacterial infections in pediatric Hodgkin's disease: re lationship radiotherapy, chemotherapy and splenectomy. Cancer 41:1949-1958
11. Nowicka J, Mazur G, Kuliczkowski K et al (1994) Cryptococcal infection and lym phogranulomatous infiltration of the central nervous system in Hodgkin's disease. Mycoses 37:439-441
12. Rajkumar K, Rajkumar T, Sagar TG et al (1992) Cryp tococcal meningitis in a patient with Hodgkin's lymphoma. J Assoc Physicians India 40: 707-708.
13. Iacopino P, Morabito F, Martino B et al (1991) Fluconazole for disseminated Cryptococcosis in a patient with Hodgkin's disease. Haematologica 76:260.
14. Arico M, Danesino C, Pende D, Moretta I (2001) Pathogenesis of hae mo pha go cytic lymphohistiocytosis. Br J Haematol 114:761-769
15. Hasselblom S, Linde A, Ridell B (2004) Hodgkin'slymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome. J Inter Med 255:289-295